360 related articles for article (PubMed ID: 32561686)
1. Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
J Pharmacol Exp Ther; 2020 Sep; 374(3):354-365. PubMed ID: 32561686
[TBL] [Abstract][Full Text] [Related]
2. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
[TBL] [Abstract][Full Text] [Related]
3. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA.
Dos Santos Rodrigues B; Kanekiyo T; Singh J
Nanomedicine; 2020 Aug; 28():102225. PubMed ID: 32485318
[TBL] [Abstract][Full Text] [Related]
5. Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes.
Dos Santos Rodrigues B; Arora S; Kanekiyo T; Singh J
Brain Res; 2020 May; 1734():146738. PubMed ID: 32081534
[TBL] [Abstract][Full Text] [Related]
6. ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles.
Dos Santos Rodrigues B; Kanekiyo T; Singh J
Pharm Res; 2019 Sep; 36(11):161. PubMed ID: 31529284
[TBL] [Abstract][Full Text] [Related]
7. Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection.
Dos Santos Rodrigues B; Oue H; Banerjee A; Kanekiyo T; Singh J
J Control Release; 2018 Sep; 286():264-278. PubMed ID: 30071253
[TBL] [Abstract][Full Text] [Related]
8. Functionalized liposomal nanoparticles for efficient gene delivery system to neuronal cell transfection.
Dos Santos Rodrigues B; Banerjee A; Kanekiyo T; Singh J
Int J Pharm; 2019 Jul; 566():717-730. PubMed ID: 31202901
[TBL] [Abstract][Full Text] [Related]
9. Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease.
Arora S; Layek B; Singh J
Mol Pharm; 2021 Feb; 18(2):714-725. PubMed ID: 32787268
[TBL] [Abstract][Full Text] [Related]
10. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.
Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J
J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036
[TBL] [Abstract][Full Text] [Related]
11. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.
Rodrigues BDS; Kanekiyo T; Singh J
Mol Pharm; 2020 Jun; 17(6):2054-2063. PubMed ID: 32315185
[TBL] [Abstract][Full Text] [Related]
12. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of TAT or QLPVM coupled to receptor targeted liposomes for delivery of anticancer therapeutics to brain in vitro and in vivo.
Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J
Nanomedicine; 2020 Jan; 23():102112. PubMed ID: 31669083
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
15. Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT.
Zong T; Mei L; Gao H; Shi K; Chen J; Wang Y; Zhang Q; Yang Y; He Q
J Pharm Sci; 2014 Dec; 103(12):3891-3901. PubMed ID: 25339554
[TBL] [Abstract][Full Text] [Related]
16. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
[TBL] [Abstract][Full Text] [Related]
17. Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.
Kong L; Li XT; Ni YN; Xiao HH; Yao YJ; Wang YY; Ju RJ; Li HY; Liu JJ; Fu M; Wu YT; Yang JX; Cheng L
Int J Nanomedicine; 2020; 15():2841-2858. PubMed ID: 32425521
[TBL] [Abstract][Full Text] [Related]
18. Transferrin-modified liposome promotes α-mangostin to penetrate the blood-brain barrier.
Chen ZL; Huang M; Wang XR; Fu J; Han M; Shen YQ; Xia Z; Gao JQ
Nanomedicine; 2016 Feb; 12(2):421-30. PubMed ID: 26711963
[TBL] [Abstract][Full Text] [Related]
19. Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection.
Sharma G; Modgil A; Layek B; Arora K; Sun C; Law B; Singh J
J Control Release; 2013 Apr; 167(1):1-10. PubMed ID: 23352910
[TBL] [Abstract][Full Text] [Related]
20. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
